Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.68
Bid: 42.72
Ask: 42.84
Change: 1.06 (2.55%)
Spread: 0.12 (0.281%)
Open: 42.28
High: 42.84
Low: 42.12
Prev. Close: 41.62
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

6 Jul 2022 15:32

RNS Number : 5737R
Assura PLC
06 July 2022
 

6 July 2022

Assura plc ("Company")

Result of AGM

 

Assura plc announces that at its Annual General Meeting held earlier today, each of the resolutions submitted to the meeting (as set out in the Notice of the Meeting dated 1 June 2022) were passed by the requisite majorities on a poll.

Resolution

For

%

For

Against

% Against

Total Votes Cast (% of issued share capital)

Votes Withheld

1. To receive the Company's report and accounts

2,536,398,504

99.25

19,045,186

0.75

2,555,443,690 (86.43)

4,911,379

2. To approve the Directors' Remuneration Policy

2,512,011,438

98.11

48,281,965

1.89

2,560,293,403 (86.60)

61,666

3. To approve the Directors' Remuneration Report

2,522,696,378

98.53

37,581,807

1.47

2,560,278,185 (86.60)

76,884

4. To re-appoint Ernst & Young LLP as auditor of the Company 

2,511,745,712

98.10

48,594,581

1.90

2,560,340,293 (86.60)

14,776

5. To authorise the Audit Committee to determine the auditor's remuneration 

2,526,741,114

98.69

33,558,682

1.31

2,560,299,796 (86.60)

55,273

6. To re-elect Ed Smith as a Director of the Company

2,474,673,155

96.65

85,649,713

3.35

2,560,322,868 (86.60)

32,201

7. To re-elect Louise Fowler as a Director of the Company

2,544,566,232

99.38

15,759,757

0.62

2,560,325,989 (86.60)

29,080

8. To re-elect Jonathan Murphy as a Director of the Company

2,540,837,168

99.24

19,488,821

0.76

2,560,325,989 (86.60)

29,080

9. To re-elect Jayne Cottam as a Director of the Company

2,532,695,523

98.92

27,629,552

1.08

2,560,325,075 (86.60)

29,994

10. To re-elect Jonathan Davies as a Director of the Company

2,545,589,609

99.42

14,736,380

0.58

2,560,325,989 (86.60)

29,080

11. To re-elect Sam Barrell as a Director of the Company

2,545,932,676

99.44

14,392,399

0.56

2,560,325,075 (86.60)

29,994

12. To re-elect Emma Cariaga as a Director of the Company

2,559,436,807

99.97

888,268

0.03

2,560,325,075 (86.60)

29,994

13. To re-elect Noel Gordon as a Director of the Company

2,559,293,587

99.96

1,031,488

0.04

2,560,325,075 (86.60)

29,994

14. To authorise the Directors to allot shares

2,445,882,244

95.57

113,460,633

4.43

2,559,342,877 (86.56)

1,012,192

15. To empower the Directors to disapply pre-emption rights

2,554,885,524

99.99

239,721

0.01

2,555,125,245 (86.42)

5,229,824

16. To empower the Directors to disapply pre-emption rights in connection with an acquisition or specified capital investment

2,526,205,951

98.87

28,924,336

1.13

2,555,130,287 (86.42)

5,224,782

17. To authorise the market purchase of the Company's own shares

2,556,408,332

99.97

675,960

0.03

2,557,084,292 (86.49)

3,270,777

18. To authorise the Company to call any general meeting, other than the Annual General Meeting, by not less than 14 clear days' notice

2,402,436,333

93.83

157,906,184

6.17

2,560,342,517 (86.60)

12,552

Resolutions 1-14 were passed as ordinary resolutions. Resolutions 15-18 were passed as special resolutions. Votes 'For' include votes at the discretion of the Chairman. 

Notes:

1. The percentages above are rounded to two decimal places.

2. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" and "against" a resolution.

3. The number of ordinary shares in issue on the share register at 6.00pm on 5 July 2022 was 2,956,564,843 of which the Total Voting Rights figure was 2,956,564,843.

Copies of resolutions 15-18, being resolutions other than resolutions concerning ordinary business passed by the Company at the above AGM, have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

- Ends -

For more information, please contact:

 

Assura plc

 

Tel: 01925 945354

Orla Ball, Company Secretary

David Purcell, Investor Relations Director

 

Email: Investor@assura.co.uk

FGS Global

Gordon SimpsonJames Thompson

Tel: 0207 251 3801

Email: Assura@fgsglobal.com

 

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Warrington, UK - caring for more than 600 primary healthcare buildings, from which almost seven million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2022, Assura's portfolio was valued at £2,752 million.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. 

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association Assura plc LEI code: 21380026T19N2Y52XF72

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSSFFLMEESEDW
Date   Source Headline
1st May 20242:30 pmRNSHolding(s) in Company
1st May 20247:00 amRNSNotice of Year End Results
30th Apr 20247:00 amRNSTotal Voting Rights
16th Apr 20247:40 amRNSDirector/PDMR Shareholding
8th Apr 20244:34 pmRNSDirector/PDMR Shareholding
8th Apr 20247:00 amRNSScrip Dividend Declaration
22nd Mar 20242:18 pmRNSHolding(s) in Company
14th Mar 20248:30 amRNSScrip Calculation Price
6th Mar 20241:26 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSNotice of Dividend
8th Feb 20242:00 pmRNSCapital Markets Event
7th Feb 20242:33 pmRNSDirector/PDMR Shareholding
1st Feb 20249:32 amRNSTotal Voting Rights
16th Jan 20248:26 amRNSDirector/PDMR Shareholding
10th Jan 20247:00 amRNSTrading Update
9th Jan 20248:59 amRNSDirector/PDMR Shareholding
8th Jan 20247:00 amRNSScrip Dividend Declaration
21st Dec 20234:20 pmRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSScrip Calculation Price
6th Dec 20232:57 pmRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSNotice of Dividend
16th Nov 20237:00 amRNSAssura Plc Interim Results
8th Nov 20232:32 pmRNSDirector/PDMR Shareholding
1st Nov 20237:00 amRNSAppointment of Board Fellow
31st Oct 20237:00 amRNSNotice of Interim Results
31st Oct 20237:00 amRNSTotal Voting Rights
16th Oct 20232:04 pmRNSDirector/PDMR Shareholding
9th Oct 202311:13 amRNSDirector/PDMR Shareholding
9th Oct 20238:11 amRNSScrip Dividend Declaration
9th Oct 20237:00 amRNSRefinancing of RCF & new sustainability linkage
9th Oct 20237:00 amRNSTrading Update
18th Sep 20239:51 amRNSVesting and sale of restricted shares
14th Sep 20239:20 amRNSScrip Calculation Price
31st Aug 20237:00 amRNSNotice of Dividend
24th Aug 20238:36 amRNSHolding(s) in Company
8th Aug 20235:05 pmRNSDirector/PDMR Shareholding
31st Jul 20239:57 amRNSTotal Voting Rights
24th Jul 20237:00 amRNSDevelopment update
14th Jul 20231:47 pmRNSDirector/PDMR Shareholding
13th Jul 20234:47 pmRNSExercise of Nil Cost Options under PSP
12th Jul 20234:36 pmRNSDirector/PDMR Shareholding
10th Jul 202312:38 pmRNSHolding(s) in Company
10th Jul 20239:20 amRNSHolding(s) in Company
10th Jul 20237:00 amRNSScrip Dividend Declaration & Additional Listing
6th Jul 20232:47 pmRNSResult of AGM
6th Jul 202312:28 pmRNSDirector/PDMR Shareholding
6th Jul 20237:00 amRNSTrading Update
3rd Jul 20237:00 amRNSChange of Registered Office
29th Jun 20234:46 pmRNSHolding(s) in Company
29th Jun 20237:00 amRNSCompletion of 100th development

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.